Absci Corp (ABSI) stock

ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30

$8.45−0.69 (-7.50%)

Close on Nov 13, 2026Market cap $1.45BP/E –Yield –

Absci ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Absci's ebitda for the twelve months ending Sep 30, 2026 was -$120.10M. For fiscal 2025 it was -$108.58M. The highest annual figure on record is -$12.17M in fiscal 2020.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$108.58M	–
FY2024	Dec 31, 2024	-$95.50M	–
FY2023	Dec 31, 2023	-$101.52M	–
FY2022	Dec 31, 2022	-$93.71M	–
FY2021	Dec 31, 2021	-$68.58M	–
FY2020	Dec 31, 2020	-$12.17M	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$32.31M	–
Q2 FY2026	Jun 30, 2026	-$31.46M	–
Q1 FY2026	Mar 31, 2026	-$28.12M	–
Q4 FY2025	Dec 31, 2025	-$28.21M	–
Q3 FY2025	Sep 30, 2025	-$27.31M	–
Q2 FY2025	Jun 30, 2025	-$28.39M	–
Q1 FY2025	Mar 31, 2025	-$24.66M	–
Q4 FY2024	Dec 31, 2024	-$26.54M	–
Q3 FY2024	Sep 30, 2024	-$25.54M	–
Q2 FY2024	Jun 30, 2024	-$23.34M	–
Q1 FY2024	Mar 31, 2024	-$20.08M	–
Q4 FY2023	Dec 31, 2023	-$21.26M	–
Q3 FY2023	Sep 30, 2023	-$19.79M	–
Q2 FY2023	Jun 30, 2023	-$39.49M	–
Q1 FY2023	Mar 31, 2023	-$20.98M	–
Q4 FY2022	Dec 31, 2022	-$17.51M	–
Q3 FY2022	Sep 30, 2022	-$24.56M	–
Q2 FY2022	Jun 30, 2022	-$25.75M	–
Q1 FY2022	Mar 31, 2022	-$25.90M	–
Q4 FY2021	Dec 31, 2021	-$23.50M	–
Q3 FY2021	Sep 30, 2021	-$18.92M	–
Q2 FY2021	Jun 30, 2021	-$15.49M	–
Q1 FY2021	Mar 31, 2021	-$10.67M	–
Q4 FY2020	Dec 31, 2020	-$4.28M	–
Q3 FY2020	Sep 30, 2020	-$3.03M	–
Q2 FY2020	Jun 30, 2020	-$2.55M	–